If we had a very experienced manager of pharma r&d pipeline projects and he had the job…
- User
If we had a very experienced manager of pharma r&d pipeline projects and he had the job of managing a portfolio of IT projects (that may or may not work). How would he approach the problem?
Assistant
Fascinating scenario! A pharma R&D portfolio manager would bring a highly structured, scientifically rigorous approach to IT project management. Here's how they'd likely approach it:
1. Portfolio Composition Strategy
Diversification Principle
- Staged Risk Profile:
- Early-stage exploratory projects (high risk/high potential)
- Mid-stage development projects (moderate risk)
- Late-stage, near-implementation projects (low risk)
Probability of Success (PoS) Framework
- Assign explicit probability of success to each project
- Categorize projects by:
- Technical feasibility
- Alignment with strategic objectives
- Potential transformative impact
- Resource requirements
2. Evaluation Methodology
Rigorous Screening Process
- Initial Assessment:
- Detailed technical due diligence
- Comprehensive risk assessment
- Potential market/organizational impact
- Required capabilities and dependencies
Quantitative Evaluation
- Risk-Adjusted Net Present Value (rNPV)
- Probability-weighted value calculation
- Explicit modeling of uncertainty
- Multiple scenario analysis
Decision Gates
- Structured stage-gate process similar to clinical trials:
- Concept stage
- Proof of concept
- Prototype development
- Pilot implementation
- Full-scale rollout
3. Resource Allocation
Dynamic Resource Management
- Flexible funding model:
- Small initial investments
- Incremental funding based on milestones
- Easy "kill" options for underperforming projects
Talent Allocation
- Assign cross-functional teams
- Ensure critical skills are available
- Create "innovation pools" of specialized talent
4. Uncertainty Management
Probabilistic Modeling
- Monte Carlo simulations
- Scenario planning
- Sensitivity analysis of key variables
Real Options Approach
- Treat projects as "options" with:
- Option to expand
- Option to pivot
- Option to abandon
5. Governance and Monitoring
Continuous Evaluation
- Regular portfolio review meetings
- Objective, data-driven performance tracking
- Rapid decision-making on project continuation
Metrics Dashboard
- Technical progress indicators
- Resource utilization
- Probability of success updates
- Alignment with strategic objectives
6. Learning and Adaptation
Post-Project Analysis
- Detailed retrospectives
- Update probability models
- Capture institutional learning
- Refine screening and evaluation processes
7. Unique Pharma R&D Insights Applied
Scientific Rigor
- Treat IT projects like drug development:
- Hypothesis-driven approach
- Explicit uncertainty quantification
- Systematic risk management
Cultural Approach
- Embrace failure as part of innovation
- Focus on learning, not blame
- Systematic, repeatable processes
Practical Example
Hypothetical IT Project Evaluation
Project: AI-Powered Customer Service Platform
-
Initial Assessment:
- Technical Feasibility: 40% PoS
- Strategic Alignment: High
- Required Investment: $2M
- Potential Annual Value: $10M
-
rNPV Calculation:
- Expected Value = (0.4 × 2M)
- Adjusted Expected Value: $2.4M
-
Decision:
- Proceed with small initial prototype
- Clear milestones for continued investment
- Explicit "pivot or kill" decision points
Key Differentiators from Typical IT Management
- Quantitative rigor
- Explicit uncertainty modeling
- Systematic learning
- Portfolio-level optimization
- Scientific approach to innovation
Would you like me to elaborate on any specific aspect of this approach? I can dive deeper into the probabilistic modeling, the stage-gate process, or provide more detailed examples of how a pharma R&D approach differs from traditional IT project management.
- Staged Risk Profile:
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.